MYCN and neuroblastoma: This immune exclusion is particularly pronounced in MYCN-amplified tumours (~25% of neuroblastomas), which exhibit transcriptional repression of interferon-stimulated genes, impaired antigen presentation, and reduced infiltration of CD8+ T cells and NK cells23–25.